Safety of Propofol Sedation ( > 200 mg) for Colonoscopy.

Status Recruiting

Clinical Trial Summary

This study examines that the use of >200 mg of propofol sedation enables patients to drive home safely after outpatient colonoscopy.

Clinical Trial Description

The hospital policy of routine discharge to normal activity 1 hour after propofol mono-sedation for EGD or colonoscopy was approved by the ethics committee of Showa Inan General Hospital in January, 2004 (http://www.sihp.jp). The investigator' s subsequent experience verified the safety of this discharge policy which was reconfirmed in March 2014. Based on these studies, the upper limit of 200 mg was established for those allowed early discharge and driving to home. This study examines that the use of >200 mg of propofol sedation enables patients to drive home safely 90-120 minutes after outpatient colonoscopy. ;

Study Design

Related Conditions & MeSH terms

Safety Issues

Clinical Trial Details

NCT number	NCT05213208
Study type	Observational [Patient Registry]
Source	Showa Inan General Hospital
Contact	Akira Horiuchi, MD
Phone	09021684311
Email	horiuchi.akira@sihp.jp
Status	Recruiting
Phase
Start date	January 16, 2022
Completion date	December 31, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04485481` - Single and Multiple Ascending Dose Study of ADX-914 in Healthy Adult Volunteers	Phase 1
Completed	`NCT03473236` - Phase 1A Safety Trial of Inhaled PK10571 (GB002)	Phase 1
Not yet recruiting	`NCT03683953` - The Treatment of Bronchopulmonary Dysplasia by Intratracheal Instillation of Mesenchymal Stem Cells	Phase 1
Recruiting	`NCT05546567` - NOPARK Open Label Extension Study	N/A
Recruiting	`NCT05413226` - Effect of Different Ingestion Doses of Celastrol on Human Sperm Motility	N/A
Recruiting	`NCT05112159` - Study of IPG1094 in Healthy Participants	Phase 1
Completed	`NCT04689035` - A Phase 1 Study in Healthy Volunteers to Evaluate the Safety, Tolerability and Pharmacokinetics of AVLX-144	Phase 1
Completed	`NCT04335045` - Phase I Study of PH100 (Ecklonia Cava Phlorotannins)	Phase 1
Completed	`NCT05037227` - Safety Profile Following Inactivated COVID-19 Vaccine in Healthy Adults Aged >18 Years in Indonesia
Recruiting	`NCT05517291` - DCB Versus Primary Selective Stenting in TASC C/D Femoropopliteal Artery Disease	N/A
Recruiting	`NCT04573049` - The Effectiveness and Safety of Levosimendan in Patients With Severe Aortic Stenosis and Heart Failure Undergoing Transcatheter Aortic Valve Replacement	Phase 4
Completed	`NCT05585463` - Safety of Acupuncture and Intracutaneous Needles in Pediatric Cancer Patients: a Retrospective Study (ACUSAFE2021)
Completed	`NCT04188821` - Reduction of Seroma and Improvement of QoL in Breast Reconstruction With Tissue Expander	N/A
Completed	`NCT03667430` - Safety Evaluation of Porous Silica in Men	N/A
Completed	`NCT04499482` - Safety and Tolerability of Soy Fiber	N/A
Not yet recruiting	`NCT06087913` - Safety and PK Multi-dose Study of TAF/EVG Vaginal Insert	Phase 1
Completed	`NCT03141905` - Sick-Day Protocol to Improve Outcomes in Chronic Kidney Disease	N/A
Completed	`NCT05244161` - A Quasi-experimental Evaluation of the Malezi Program in Tanzania	N/A
Recruiting	`NCT03791372` - Clinical Effect and Safety of Autologous Umbilical Cord Blood Transfusion in the Treatment of Cerebral Palsy	Phase 1
Not yet recruiting	`NCT04774900` - Standardization of Ambulance Equipment